Tagomics

Tagomics is a company headquartered in the United Kingdom. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.

Tagomics develops a proprietary multiomic platform that combines genomics, epigenomics, and fragmentomics to unlock disease-associated biomarkers from biological sources, enabling more comprehensive insights into diseases such as cancer for improved diagnosis and treatment.